C3AR1 and neoplasm: Complement component 3a receptor 1 (C3aR1) antagonists restrained neutrophil mobilization, and melanoma-bearing C3aR1-deficient mice had reduced tumor growth and frequency of heme oxygenase 1 (HO-1) expressing monocytic blood precursors of HO-1+ TAMs [23,28].